Cargando…

Calculated parenteral initial treatment of bacterial infections: Introduction and antibiotics

This is the first chapter of the guideline “Calculated initial parenteral treatment of bacterial infections in adults – update 2018” in the 2(nd) updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been translated to address an international audien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bodmann, Klaus-Friedrich, Kresken, Michael, Grabein, Béatrice, Dohmen, Pascal M., Wilke, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	German Medical Science GMS Publishing House 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186804/ https://www.ncbi.nlm.nih.gov/pubmed/32373444 http://dx.doi.org/10.3205/id000063

Ejemplares similares

S2k guideline “Calculated parenteral initial treatment of bacterial infections in adults – update 2018”, 2(nd) updated version: Foreword
por: Bodmann, Klaus-Friedrich, et al.
Publicado: (2020)

Calculated initial parenteral treatment of bacterial infections: Sepsis
por: Bodmann, Klaus-Friedrich, et al.
Publicado: (2020)

Calculated initial parenteral treatment of bacterial infections: Bacterial endocarditis
por: Dohmen, Pascal M., et al.
Publicado: (2020)

Calculated parenteral initial treatment of bacterial infections: Microbiology
por: Kresken, Michael, et al.
Publicado: (2020)

Calculated parenteral initial treatment of bacterial infections: Respiratory infections
por: Ott, Sebastian R., et al.
Publicado: (2020)

Calculated parenteral initial treatment of bacterial infections: Economic aspects of antibiotic treatment
por: Wilke, Michael, et al.
Publicado: (2020)

Calculated parenteral initial treatment of bacterial infections: Infections with multi-resistant Gram-negative rods – ESBL producers, carbapenemase-producing Enterobacteriaceae, carbapenem-resistant Acinetobacter baumannii
por: Grabein, Béatrice, et al.
Publicado: (2020)

Calculated parenteral initial therapy of bacterial infections: Antibiotic treatment in the elderly
por: Walger, Peter, et al.
Publicado: (2020)

Calculated initial parenteral treatment of bacterial infections: Bacterial gastrointestinal infections
por: Mutters, Reinier, et al.
Publicado: (2020)

Calculated parenteral initial therapy of bacterial infections: Bacterial meningitis
por: Shah, Pramod M., et al.
Publicado: (2020)

Calculated initial parenteral treatment of bacterial infections: Safety and tolerabilty
por: Stahlmann, Ralf, et al.
Publicado: (2020)

Calculated initial parenteral treatment of bacterial infections: Pharmacokinetics and pharmacodynamics
por: Derendorf, Hartmut, et al.
Publicado: (2020)

Calculated parenteral initial treatment of bacterial infections: Bone and joint infections
por: Vossen, Mathias G., et al.
Publicado: (2020)

Calculated parenteral initial treatment of bacterial infections: Intra-abdominal infections
por: Eckmann, Christian, et al.
Publicado: (2020)

Calculated initial parenteral treatment of bacterial infections: Skin and soft tissue infections
por: Sunderkötter, Cord, et al.
Publicado: (2020)

Calculated parenteral initial treatment of bacterial infections: Infections of the kidneys and the genito-urinary tract
por: Fünfstück, Reinhard, et al.
Publicado: (2020)

Clinical and economical improvements after introducing rapid identification of bacteria and early antibiotic susceptibility testing in sepsis and bloodstream infections. Results of the PHENOMENON study
por: Wilke, Michael, et al.
Publicado: (2020)

Calculated parenteral initial treatment of bacterial infections: Infections in the ear, nose, throat and mouth and jaw area
por: Olzowy, Bernhard, et al.
Publicado: (2020)

Guideline-adherent initial intravenous antibiotic therapy for hospital-acquired/ventilator-associated pneumonia is clinically superior, saves lives and is cheaper than non guideline adherent therapy
por: Wilke, MH, et al.
Publicado: (2011)

Potential savings through single-dose intravenous Dalbavancin in long-term MRSA infection treatment – a health economic analysis using German DRG data
por: Wilke, Michael, et al.
Publicado: (2019)

Therapie der Zystitis mit Nitroxolin – NitroxWin: Prospektive, multizentrische, nicht-interventionelle Studie und mikrobiologische Untersuchungen zur Resistenzsituation
por: Wagenlehner, Florian, et al.
Publicado: (2023)

Susceptibility of clinical isolates of frequently encountered bacterial species to tigecycline one year after the introduction of this new class of antibiotics: results of the second multicentre surveillance trial in Germany (G-TEST II, 2007)
por: Kresken, M., et al.
Publicado: (2009)

Outpatient parenteral antibiotic therapy (OPAT) for the management of bronchiectasis
por: Tu, Jacky, et al.
Publicado: (2023)

Temporal trends of the in vitro activity of tigecycline and comparator antibiotics against clinical aerobic bacterial isolates collected in Germany, 2006–2014: results of the Tigecycline Evaluation and Surveillance Trial (TEST)
por: Kresken, Michael, et al.
Publicado: (2016)

Introduction and methodology – Guidelines on Parenteral Nutrition, Chapter 1
por: Koletzko, B., et al.
Publicado: (2009)

Hypersensitivity to parenteral antibiotics in patients with cystic fibrosis
por: Roehmel, Jobst, et al.
Publicado: (2014)

Algorithm for Calculating the Protein Intake in Enteral and Parenteral Nutrition in Premature Infants
por: STOICĂNESCU, E.C., et al.
Publicado: (2018)

Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis
por: Duncan, Christopher J. A., et al.
Publicado: (2013)

Intraluminal antibiotic treatment of central venous catheter infection in patients receiving total parenteral nutrition
por: Alivizatos, V, et al.
Publicado: (2000)

Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria
por: Pericàs, Juan M, et al.
Publicado: (2022)

Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections
por: Altmann, Dominique, et al.
Publicado: (2023)

The use of a standardized PCT-algorithm reduces costs in intensive care in septic patients - a DRG-based simulation model
por: Wilke, MH, et al.
Publicado: (2011)

Parenteral Antibiotics Reduce Bifidobacteria Colonization and Diversity in Neonates
por: Hussey, Séamus, et al.
Publicado: (2011)

Acute dental infections managed in an outpatient parenteral antibiotic program setting: prospective analysis and public health implications
por: Connors, William J., et al.
Publicado: (2017)

Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore
por: Chan, Monica, et al.
Publicado: (2017)

Mikrobiologie und Antiinfektiva
por: Grabein, Béatrice, et al.
Publicado: (2011)

Mikrobiologie und Antiinfektiva
por: Grabein, Béatrice, et al.
Publicado: (2013)

177 Management of Complicated Para-pneumonic Effusion and Pleural Empyema with Initial Parenteral Antibiotics and Early Switch to Oral Equivalent
por: Espinosa, Claudia, et al.
Publicado: (2014)

Implementation of a consensus protocol for antibiotic use for bone and joint infection to reduce unnecessary outpatient parenteral antimicrobial therapy: A quality improvement initiative
por: Suzuki, Hiroyuki, et al.
Publicado: (2022)

Managing an outpatient parenteral antibiotic therapy team: challenges and solutions
por: Halilovic, Jenana, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_f06l5js7dogr72oph2re8ggm4p